| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Chief Business Officer
1 company
Kulkarni Samarth is a Chief Executive Officer at CRSP. Recent filings cover 0 purchases and 109 sales. Those positions are worth an estimated $15.5M at current prices.
Our model assigns Kulkarni Samarth a middling insider score of 68/100, based on 37 past trades. Over a 12-month horizon, 58.1% of those trades were profitable, with an average 12-month return of +7.5%.
Kulkarni Samarth's largest disclosed position is in CRSP as Chief Executive Officer, worth about $15.5M. The recent filings there lean toward selling, a net 1,049,894 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 20, 2024 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 6,370 | $79.67 | $507,497.90 | -3.2% | -29.5% | -32.7% | |
| Feb 15, 2024 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 20,000 | $80.36 | $1,607,177.46 | -9.6% | -32.6% | -41.1% | |
| Jan 29, 2024 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 50,000 | $60.51 | $3,025,572.69 | -21.1% | -16.6% | -36.4% | |
| Jan 16, 2024 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 20,000 | $62.50 | $1,250,058.00 | -9.6% | -7.4% | -38.5% | |
| May 30, 2023 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 25,000 | $64.88 | $1,621,894.25 | -6.1% | -22.7% | -16.7% | |
| Apr 25, 2023 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 25,000 | $50.67 | $1,266,637.58 | -6.1% | +12.3% | +12.6% | |
| Mar 29, 2023 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 25,000 | $44.46 | $1,111,503.52 | -6.1% | +23.6% | +50.9% | |
| Feb 27, 2023 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 25,000 | $48.25 | $1,206,243.36 | -6.2% | +31.5% | +81.3% | |
| Jan 27, 2023 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 25,000 | $51.47 | $1,286,797.52 | -6.3% | -7.0% | +15.6% | |
| Dec 28, 2022 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 25,000 | $40.93 | $1,023,290.03 | -6.3% | +11.9% | +64.1% |